LEADER 01141nam2-2200349---450 
001 990006038280203316
005 20231212115933.0
010   $a978-0-12-397918-6
035   $a000603828
035   $aUSA01000603828
035   $a(ALEPH)000603828USA01
035   $a000603828
100   $a20090918h2014----km-y0itay50------ba
101   $aeng
102   $aNE
105   $aa---||||001yy
200 1 $aProtein kinase inhibitors in research and medicine$fedited by Kevan M. Shokat
210   $aAmsterdam...[etc.]$cElsevier$dcopyr. 2014
215   $aXII, 241 p., [21] c. di tav.$cill.$d23 cm
225 2 $aMethods in enzymology$v548
410  0$1001990002876030203316$12001$aMethods in enzymology$v548
606 0 $aBiomedicina$xRicerca scientifica$xProteina chinasi C$xMetodi$2BNCF
676   $a612.01516
702  1$aSHOKAT,$bKevan M.
801  0$aIT$bsalbc$gISBD
912   $a990006038280203316
951   $a572.7 MET/548$b5856 Farm.$c572$d00330802
959   $aBK
969   $aFAR
979   $aPAOLA$b90$c20150513$lUSA01$h1601
996   $aProtein kinase inhibitors in research and medicine$91075847
997   $aUNISA